EU Cosmetic INCI Screening: Annex II and III Compliance Guide
How FMCG brands screen raw material INCI names against EU Regulation (EC) No 1223/2009 Annex II prohibited and Annex III restricted lists, trace impurities, and CPNP gates.
Placing a cosmetic product on the European Union market requires strict compliance with Regulation (EC) No 1223/2009. FMCG brands, chemical suppliers, and importers must verify every raw material against regulatory annexes before entering formulation or investing in packaging artwork. Discovering a banned ingredient or exceeding a concentration limit late in development forces costly formulation restarts and delays market launch.
The legal reality of EU cosmetic formulation
Regulatory compliance begins with understanding the single source of truth under European law. Only Regulation (EC) No 1223/2009 and its official amendments establish binding legal restrictions for cosmetic ingredients in the EU. Formulators frequently rely on the European Commission CosIng database for quick chemical searches. However, CosIng is explicitly a non-legally binding information tool according to its official registry documentation.
When discrepancies arise between CosIng listings and the published text of Regulation (EC) No 1223/2009 in the Official Journal of the European Union, the Regulation remains the sole legal authority. CosIng distinguishes between labeling ingredients marked with an uppercase I and regulated substances marked with an S. A substance appearing in CosIng does not imply legal authorization or safety approval. Compliance teams must reference official consolidated legal texts on EUR-Lex to verify restricted entries under column references in Annex II through VI.
Prohibited Annex II traces and restricted Annex III limits
Substance restrictions fall under distinct regulatory frameworks depending on the targeted Annex classification. Article 14(1)(a) strictly prohibits any cosmetic product from containing substances listed in Annex II. However, Article 17 provides a narrow exception for non-intended trace impurities stemming from natural ingredients, synthetic synthesis, manufacturing processes, storage, or packaging migration. Trace amounts are legally permitted only if technologically unavoidable under Good Manufacturing Practice and fully safe under Article 3.
Annex III establishes conditions for restricted substances permitted only under specific limits. For example, fragrance allergens listed in Annex III entries 67 to 92 require explicit labeling disclosure when concentrations exceed 0.001% in leave-on products or 0.01% in rinse-off products. Other substances carry strict usage bans, such as Boric Acid (Annex III entry 1a), which is limited to 3% in general cosmetics and prohibited in products for children under 3 years of age.
Comparison of EU cosmetic regulatory gates
Navigating ingredient restrictions requires mapping formulation data against specific legal obligations. The following comparison outlines the primary regulatory mechanisms under Regulation (EC) No 1223/2009.
| Regulatory Mechanism | Target Scope | Legal Requirement | Technical Threshold |
|---|---|---|---|
| Annex II Prohibited List | Banned substances (e.g. Benzene) | Total ban in finished cosmetics | Zero allowance; Article 17 trace exceptions require GMP proof |
| Annex III Restricted List | Restricted ingredients (e.g. Salicylic acid) | Concentration and target user limits | Maximum 2.0% to 3.0%; banned in children under 3 years |
| Fragrance Allergen Rules | 26+ listed fragrance compounds | Mandatory explicit packaging disclosure | > 0.001% leave-on; > 0.01% rinse-off preparations |
| Article 16 Nanomaterials | Particles scaled 1 to 100 nm | Electronic CPNP notification | Mandatory notification 6 months prior to launch date |
Understanding these thresholds prevents regulatory enforcement actions, product recalls under Article 25, and national administrative penalties enforced across EU member states.
Responsible Person duties and CPNP notifications
Every cosmetic product placed on the EU market must have a designated Responsible Person established within the European Union under Article 4. For EU manufacturers, the manufacturer acts as the default Responsible Person. For imported goods from third countries, the importer automatically inherits Responsible Person duties unless another EU entity is designated in writing. The Responsible Person holds legal liability for compiling the Cosmetic Product Safety Report signed by a university-qualified safety assessor under Article 10(2).
Before market launch, the Responsible Person must submit an electronic notification to the Cosmetic Products Notification Portal under Article 13. Formulations containing intentionally manufactured nanomaterials require an advanced notification six months prior to launch under Article 16. Maintaining a complete Product Information File for 10 years after the last batch is placed on the market remains a mandatory requirement under Article 11.
Automated INCI screening with fmcg.network
FMCG R&D and regulatory teams can automate ingredient screening using fmcg.network Business Capabilities. The Cosmetic INCI and Annex II/III Screen capability screens raw material lists directly against official Annex II and Annex III database tables, identifying restricted concentration limits, allergen disclosure triggers, and banned chemical entries instantly.
To run an automated INCI screening query, connect your AI client to fmcg.network and execute the capability:
“Screen the following raw material INCI list against EU Regulation (EC) No 1223/2009 Annex II and III restrictions: Salicylic acid, Benzene, Boric acid, Aqua, Glycerin.”
The assistant queries the network reference registry, retrieves specific Annex references, and returns exact conditions of use and warning requirements without asserting legal verdicts.
Install fmcg.network in Claude, ChatGPT, Copilot or Cursor, then browse the full Business Capability Directory.
Frequently Asked Questions
Does CosIng listing mean an ingredient is officially approved for EU cosmetics? No. CosIng is an information database and is strictly non-legally binding. Legal authority rests exclusively with Regulation (EC) No 1223/2009 and its published Annexes.
How to document technically unavoidable trace impurities of Annex II substances in a CPSR? Under Article 17, the safety assessor must document evidence of Good Manufacturing Practice, technological unavoidability, and toxicological safety in Part A Section 3 of the Cosmetic Product Safety Report.
Can I use Salicylic Acid as an anti-acne active above the Annex V preservative limit? Salicylic Acid used for non-preservative purposes falls under Annex III Entry 98. It is restricted to a maximum concentration of 2.0% in general cosmetics and 3.0% in rinse-off hair products, and is prohibited for children under 3 years of age.
Do I need to list fragrance allergens on the label if they are below 0.01% in a rinse-off shampoo? No. Fragrance allergens listed in Annex III require explicit labeling only when concentration exceeds 0.01% in rinse-off products or 0.001% in leave-on products.
What happens to my CPNP timeline if my sunscreen uses nano Titanium Dioxide instead of standard? Standard ingredients use immediate CPNP notification under Article 13. Nano-form ingredients require an advanced CPNP notification 6 months prior to launch under Article 16 unless previously authorized under Annex VI.
Are we legally the Responsible Person if we import a finished cosmetic from a UK supplier into Germany? Yes. Under Article 4(2), the EU-based importer automatically acts as the Responsible Person for imported cosmetics unless another EU entity is formally designated in writing.